PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Practical Roadmap for Starting and Maintaining Subcutaneous Foslevodopa/Foscarbidopa Infusion

foslevodopafoscarbidopalevodopacarbidopasubcutaneous infusionadvanced Parkinson's diseasemotor fluctuationsdevice-aided therapyinfusion site reactionsnarrative reviewdose conversion Neurology / Neuropharmacology

Background Information

New infusion approach eases motor fluctuations in advanced Parkinson's disease.

Foslevodopa/foscarbidopa provides a novel delivery method to manage advanced Parkinson's disease with continuous levodopa delivery. The infusion improves motor fluctuations and quality of life, with manageable infusion site events and systemic adverse effects. Guidance on real-world use suggests effective outpatient initiation and management, but highlights the need for patient and team education. Continuous subcutaneous infusion of foslevodopa/foscarbidopa offers stable symptom control for advanced Parkinson's disease.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Chaudhuri KR, Bergmans B, Freire-Alvarez E, Hopes L, Kern DS, Kirsner RS, Lazzeri G, Mendes-Bastos P, Nishikawa N, Odin P, Poplawska-Domaszewicz K, Pahwa R, Ramot Y, Seppi K, Warnecke T, Wiggins R, Shah MB, Kukreja P, Fritz B, Onuk K, Isaacson SH

Citation: Chaudhuri KR, Bergmans B, Freire-Alvarez E, et al. Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease. Movement disorders clinical practice. 2026;13(7):1601-1611. doi:10.1002/mdc3.70489

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.